 | Up a level |
Mark, Michael; Froesch, Patrizia; Gysel, Katrin; Rothschild, Sacha I; Addeo, Alfredo; Ackermann, Christoph J; Chiquet, Sabrina; Schneider, Martina; Ribi, Karin; Maranta, Angela Fischer; Bastian, Sara; von Moos, Roger; Joerger, Markus; Früh, Martin (2024). First-line durvalumab in patients with PD-L1 positive, advanced non-small cell lung cancer (NSCLC) with a performance status of 2 (PS2). Primary analysis of the multicenter, single-arm phase II trial SAKK 19/17. European journal of cancer, 200(113600), p. 113600. Elsevier 10.1016/j.ejca.2024.113600
Werner, Raphael Sven; Curioni-Fontecedro, Alessandra; Mauti, Laetitia A; Addeo, Alfredo; Peters, Solange; Frauenfelder, Thomas; Puhan, Milo A; Haberecker, Martina; Bubendorf, Lukas; Finazzi, Tobias; Guckenberger, Matthias; Cafarotti, Stefano; Geiser, Thomas; Opitz, Isabelle (2024). Lung Cancer in Switzerland. Journal of thoracic oncology, 19(3), pp. 385-394. Elsevier 10.1016/j.jtho.2023.12.005
Addeo, Alfredo; Rothschild, Sacha I; Holer, Lisa; Schneider, Martina; Waibel, Christine; Haefliger, Simon; Mark, Michael; Fernandez, Eugenio; Mach, Nicolas; Mauti, Laetitia; Jermann, Philip M; Alborelli, Ilaria; Calgua, Byron; Savic-Prince, Spasenija; Joerger, Markus; Früh, Martin (2022). Fibroblast growth factor receptor (FGFR) inhibitor rogaratinib in patients with advanced pretreated squamous-cell non-small cell lung cancer over-expressing FGFR mRNA: The SAKK 19/18 phase II study. Lung cancer, 172, pp. 154-159. Elsevier 10.1016/j.lungcan.2022.08.016
Jin, Kai-Qi; Liu, Xiao-Gang; Guo, Yan-Hua; Wu, Chun-Xiao; Dai, Jie; Li, Jia-Qi; Minervini, Fabrizio; Antonoff, Mara B; Friedlaender, Alex; Addeo, Alfredo; Kocher, Gregor; Grossi, Francesco; Zhu, Yu-Ming; Zhang, Peng; Jiang, Ge-Ning (2022). Adjuvant treatment for patients with incidentally resected limited disease small cell lung cancer-a retrospective study. Translational lung cancer research, 11(9), pp. 1951-1960. AME Publishing 10.21037/tlcr-22-616
